Doramapimod
Produktgrößen
5 mg
£172,00
SIH-442-5MG
25 mg
£488,00
SIH-442-25MG
Über dieses Produkt
- SKU:
- SIH-442
- Zusätzliche Namen:
- JNK Inhibitor XVII, BIRB796, 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea
- CAS Number:
- 285983-48-4
- CE/IVD:
- Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
- Weitere Details:
- Doramapimod is a highly potent and selective inhibitor of p38A Alpha mitogen-activated protein kinase (MAPK), a key regulator of inflammatory signaling. In neurodegenerative disease research, p38A Alpha MAPK is implicated in microglial activation, cytokine production, and neuronal stress responses. Doramapimod is used to explore the therapeutic potential of p38A Alpha inhibition in reducing neuroinflammation and protecting against neuronal damage in conditions such as Alzheimer's disease, ALS, and multiple sclerosis.
- Molekulargewicht:
- 527.7
- Reinheit:
- ≥99%
- Versandbedingungen:
- Ambient
- Quelle:
- Synthetic
- Lagerbedingungen:
- -20[o]C
- Hersteller:
- StressMarq Biosciences
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors
- Datenblatt des Herstellers:https://www.stressmarq.com/products/small-molecules/inhibitor/doramapimod-sih-442/